John H. Krege

12.5k citations

110 papers · 9.5k indexed · 9 hit papers · h-index 45

Orthopedics and Sports Medicine top 0.1%
- Bone health and osteoporosis research 56
- Bone and Joint Diseases 12
Endocrinology, Diabetes and Metabolism top 0.5%
Cardiology and Cardiovascular Medicine top 1%
- Renin-Angiotensin System Studies 15
Oncology top 1%
- Bone health and treatments 37
Reproductive Medicine top 1%
Psychiatry and Mental health
- Migraine and Headache Studies 22
Molecular Biology
- Bone Metabolism and Diseases 20
Pathology and Forensic Medicine
- Trigeminal Neuralgia and Treatments 16
Surgery
- Hip and Femur Fractures 14

Co-authors: Oliver Smithies Jeffrey B. Hodgin John R. Hagaman Kenneth S. Korach John F. Couse Eva Enmark Jan-Ακε Gustafsson Madhabananda Sar
Cited by: Orthopedics and Sports Medicine Endocrinology, Diabetes and Metabolism Cardiology and Cardiovascular Medicine
Journals: Nature (1 paper)Science (1 paper)New England Journal of Medicine (1 paper)
Partner nations: United States Japan Canada

In The Last Decade

John H. Krege

110 papers receiving 9.3k citations

Hit Papers

9 papers align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2025 New England Journal of Medicine
2024 JAMA
1998 Proceedings of the National Academy of Sciences
1998 Proceedings of the National Academy of Sciences
1996 Proceedings of the National Academy of Sciences
1995 Nature
1995 Proceedings of the National Academy of Sciences
1995 Science
1995 Hypertension

Peers

Countries citing papers authored by John H. Krege

Since Specialization

Citations

This map shows the geographic impact of John H. Krege's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John H. Krege with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John H. Krege more than expected).

Fields of papers citing papers by John H. Krege

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John H. Krege. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John H. Krege. The network helps show where John H. Krege may publish in the future.

Co-authorship network

The 25 scholars most cited alongside John H. Krege, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John H. Krege Line = papers co-authored together John H. Krege links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Impact of Lipoprotein(a) on Valvular and Cardiovascular Outcomes in Patients With Calcific Aortic Valve Stenosis Journal of the American Heart Association ·Arnaud Girard,Audrey Paulin,Hasanga D. Manikpurage,Emma Lajeunesse,Marie‐Annick Clavel,Philippe Pîbarot,John H. Krege,Patrick Mathieu,Sébastien Thériault,Benoît J. Arsenault	2025	3
2	Lepodisiran — A Long-Duration Small Interfering RNA Targeting Lipoprotein(a)breakdown → New England Journal of Medicine ·Steven E. Nissen,Wei Ni,Xi Shen,Qiuqing Wang,Ann Marie Návar,Stephen J. Nicholls,Kathy Wolski,Laura Michael,Axel Haupt,John H. Krege	2025	27
3	Long-term treatment with lasmiditan in patients with migraine: post hoc analysis of treatment patterns and outcomes from the open-label extension of the CENTURION randomized trial The Journal of Headache and Pain ·Mika Komori,Akichika Ozeki,Yuka Tanji,Eriko Kamiki,John H. Krege,Lily Qian Li,Shiho Suzuki,Mamoru Shibata,Takao Takeshima	2024	5
4	Measuring Lp(a) particles with a novel isoform-insensitive immunoassay illustrates efficacy of muvalaplin Journal of Lipid Research ·Craig Swearingen,John H. Sloan,Grace M. Rhodes,Robert W. Siegel,Nicoletta Bivi,Yuewei Qian,Robert J. Konrad,Michael B. Boffa,Marlys L. Koschinsky,John H. Krege,Giacomo Ruotolo,Stephen J. Nicholls,Laura F. Michael,Yi Wen	2024	3
5	Assessment to Identify Predictors of 2-Hour Pain Freedom among Patients Enrolled in 2 Phase 3 Studies of Lasmiditan for Acute Treatment of Migraine (1763) Neurology ·Bert B. Vargas,Delphine Magis,Erin Doty,Dustin Ruff,Raghavendra Vasudev,John H. Krege,Ann Marie Hake	2020	1
6	Trajectory of migraine-related disability following long-term treatment with lasmiditan: results of the GLADIATOR study The Journal of Headache and Pain ·Richard B. Lipton,Louise Lombard,Dustin Ruff,John H. Krege,Li Shen Loo,Andrew Buchanan,Thomas Melby,Dawn C. Buse	2020	30
7	Long-term Safety and Efficacy of Lasmiditan for Acute Treatment of Migraine Over a One-Year Period: Interim Results of an Open-Label Phase 3 Study (GLADIATOR) (P1.10-021) Neurology ·Jan Lewis Brandes,David Kudrow,Suzanne Klise,John H. Krege,Michael Case,Joel Raskin,Rashna Khanna,Raghavendra Vasudeva	2019	2
8	Effect of a rescue or recurrence dose of lasmiditan on efficacy and safety in the acute treatment of migraine: findings from the phase 3 trials (SAMURAI and SPARTAN) BMC Neurology ·Li Shen Loo,Brian M. Plato,Ira Turner,Michael Case,Joel Raskin,Sherie A. Dowsett,John H. Krege	2019	24
9	Teriparatide Treatment Increases Mineral Content and Volume in Cortical and Trabecular Bone of Iliac Crest: A Comparison of Infrared Imaging With X-Ray–Based Bone Assessment Techniques Journal of Bone and Mineral Research ·Eleftherios P. Paschalis,John H. Krege,Sonja Gamsjaeger,Erik Fink Eriksen,David B. Burr,Damon Disch,J Štěpán,Astrid Fahrleitner‐Pammer,Klaus Klaushofer,Fernando Marín,Imre Pávó	2018	9
10	Improvement of cancellous bone microstructure in patients on teriparatide following alendronate pretreatment Bone ·Astrid Fahrleitner‐Pammer,David B. Burr,Harald Dobnig,J Štěpán,Helmut Petto,Jiliang Li,John H. Krege,Imre Pávó	2016	16
11	Patients with prior vertebral or hip fractures treated with teriparatide in the Direct Assessment of Nonvertebral Fractures in Community Experience (DANCE) observational study Osteoporosis International ·Douglas P. Beall,Robert G. Feldman,Michael Gordon,Barbara Gruber,Joseph M. Lane,Guillermo J. Valenzuela,D. Yim,Jahangir Alam,John H. Krege,Kelly Krohn	2015	5
12	Effects of Teriparatide in Postmenopausal Women With Osteoporosis on Prior Alendronate or Raloxifene: Differences Between Stopping and Continuing the Antiresorptive Agent Obstetrical & Gynecological Survey ·Felicia Cosman,Robert A. Wermers,Christopher Recknor,Karen F. Mauck,Li Xie,Emmett V. Glass,John H. Krege	2010	3
13	Effects of Teriparatide in Postmenopausal Women with Osteoporosis on Prior Alendronate or Raloxifene: Differences between Stopping and Continuing the Antiresorptive Agent The Journal of Clinical Endocrinology & Metabolism ·Felicia Cosman,Robert A. Wermers,Christopher Recknor,Karen F. Mauck,Li Xie,Emmett V. Glass,John H. Krege	2009	125
14	Enhanced prediction of fracture risk combining vertebral fracture status and BMD Osteoporosis International ·Ethel S. Siris,Harry K. Genant,Andrew J. Laster,P. Chen,Derek Misurski,John H. Krege	2007	154
15	New or Worsening Lumbar Spine Vertebral Fractures Increase Lumbar Spine Bone Mineral Density and Falsely Suggest Improved Skeletal Status Journal of Clinical Densitometry ·John H. Krege,Paul D. Miller,Leon Lenchik,Derek Misurski,Peiqi Chen	2006	10
16	Safety and Efficacy of Teriparatide in Elderly Women with Established Osteoporosis: Bone Anabolic Therapy from a Geriatric Perspective Journal of the American Geriatrics Society ·Steven Boonen,Fernando Marín,Dan Mellström,Li Xie,D. Desaiah,John H. Krege,Clifford J. Rosen	2006	97
17	Reduction in vertebral fracture risk in teriparatide-treated postmenopausal women as assessed by spinal deformity index Bone ·Harry K. Genant,Ethel S. Siris,Gerald Crans,D. Desaiah,John H. Krege	2005	18
18	The effects of teriparatide on the incidence of back pain in postmenopausal women with osteoporosis Current Medical Research and Opinion ·Harry K. Genant,Johan Halse,Walter G. Briney,Li Xie,Emmett V. Glass,John H. Krege	2005	52
19	Prognostic utility of a semiquantitative spinal deformity index Bone ·Gerald Crans,Harry K. Genant,John H. Krege	2005	102
20	A proposed relationship between vasopressinase altered vasopressin and preeclampsia Medical Hypotheses ·John H. Krege,Vern L. Katz	1990	19

About John H. Krege

John H. Krege is a scholar working on Orthopedics and Sports Medicine, Psychiatry and Mental health and Oncology, having authored 110 papers that have together received 9.5k indexed citations. Recurring topics across this work include Bone health and osteoporosis research (56 papers), Bone health and treatments (37 papers), Migraine and Headache Studies (22 papers), Bone Metabolism and Diseases (20 papers), Trigeminal Neuralgia and Treatments (16 papers), Renin-Angiotensin System Studies (15 papers), Hip and Femur Fractures (14 papers) and Bone and Joint Diseases (12 papers). The work is most often cited by research in Orthopedics and Sports Medicine (2.8k citations), Endocrinology, Diabetes and Metabolism (1.9k citations) and Cardiology and Cardiovascular Medicine (2.2k citations). John H. Krege has collaborated with scholars based in United States, Japan and Canada. Frequent co-authors include Oliver Smithies, Jeffrey B. Hodgin, John R. Hagaman, Kenneth S. Korach, John F. Couse, Eva Enmark, Jan-Ακε Gustafsson, Madhabananda Sar, Margaret Warner and Joel F. Mahler. Their work appears in journals such as Nature, Science and New England Journal of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact